LPL Financial LLC Acquires 406,976 Shares of Cryoport, Inc. (NASDAQ:CYRX)

LPL Financial LLC raised its stake in Cryoport, Inc. (NASDAQ:CYRX - Free Report) by 1,366.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 436,766 shares of the company's stock after acquiring an additional 406,976 shares during the period. LPL Financial LLC owned approximately 0.88% of Cryoport worth $3,398,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Geode Capital Management LLC increased its holdings in shares of Cryoport by 3.6% in the 3rd quarter. Geode Capital Management LLC now owns 1,097,369 shares of the company's stock worth $8,902,000 after buying an additional 38,520 shares during the last quarter. State Street Corp increased its stake in Cryoport by 2.8% during the third quarter. State Street Corp now owns 1,003,080 shares of the company's stock worth $8,135,000 after acquiring an additional 27,438 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in Cryoport by 0.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 387,714 shares of the company's stock valued at $3,144,000 after purchasing an additional 2,226 shares during the period. Franklin Resources Inc. lifted its stake in shares of Cryoport by 5.5% in the 3rd quarter. Franklin Resources Inc. now owns 385,619 shares of the company's stock valued at $3,127,000 after purchasing an additional 20,077 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in shares of Cryoport by 1,464.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 305,237 shares of the company's stock valued at $2,475,000 after purchasing an additional 285,726 shares during the last quarter. Hedge funds and other institutional investors own 92.90% of the company's stock.

Cryoport Trading Down 2.9 %

Shares of NASDAQ:CYRX traded down $0.17 on Thursday, hitting $5.45. 69,421 shares of the company's stock were exchanged, compared to its average volume of 429,859. The business's 50 day simple moving average is $6.04 and its two-hundred day simple moving average is $7.06. The company has a debt-to-equity ratio of 0.48, a current ratio of 5.70 and a quick ratio of 5.32. The stock has a market capitalization of $271.76 million, a price-to-earnings ratio of -1.61 and a beta of 1.81. Cryoport, Inc. has a 12 month low of $4.58 and a 12 month high of $17.41.

Cryoport (NASDAQ:CYRX - Get Free Report) last issued its earnings results on Tuesday, March 4th. The company reported ($0.42) EPS for the quarter, missing analysts' consensus estimates of ($0.33) by ($0.09). The company had revenue of $59.53 million during the quarter, compared to the consensus estimate of $58.71 million. Cryoport had a negative return on equity of 13.35% and a negative net margin of 70.08%. During the same quarter in the prior year, the company earned ($0.29) earnings per share. Analysts anticipate that Cryoport, Inc. will post -0.99 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Guggenheim restated a "buy" rating and set a $10.00 price target on shares of Cryoport in a report on Wednesday. Roth Mkm reissued a "buy" rating and issued a $15.00 target price on shares of Cryoport in a research note on Tuesday, April 1st. UBS Group lifted their price target on shares of Cryoport from $10.00 to $11.00 and gave the stock a "buy" rating in a research note on Tuesday, April 1st. Finally, Needham & Company LLC reiterated a "buy" rating and set a $11.00 price target on shares of Cryoport in a report on Wednesday. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $11.67.

Insider Buying and Selling at Cryoport

In other news, CEO Jerrell Shelton sold 4,620 shares of the firm's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $6.29, for a total transaction of $29,059.80. Following the transaction, the chief executive officer now owns 765,399 shares in the company, valued at approximately $4,814,359.71. This trade represents a 0.60 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders sold a total of 19,830 shares of company stock valued at $118,353 in the last ninety days. Corporate insiders own 10.10% of the company's stock.

Cryoport Profile

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.